Language

News topic

Product Atomoxe

Current shortage notices for the product family Atomoxe, structured by product, country and reporting period.

5 notices

← All shortages

What the Atomoxe notices indicate for the supply chain

The 5 consolidated notices from Germany are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Germany

Atomoxe - 1 A Pharma 10 mg Hartkapseln

Active ingredient: Atomoxetinhydrochlorid

View notice details →
Germany

Atomoxe - 1 A Pharma 100 mg Hartkapseln

Active ingredient: Atomoxetinhydrochlorid

View notice details →
Germany

Atomoxe - 1 A Pharma 18 mg Hartkapseln

Active ingredient: Atomoxetinhydrochlorid

View notice details →
Germany

Atomoxe - 1 A Pharma 25 mg Hartkapseln

Active ingredient: Atomoxetinhydrochlorid

View notice details →
Germany

Atomoxe - 1 A Pharma 60 mg Hartkapseln

Active ingredient: Atomoxetinhydrochlorid

View notice details →